electroCore (NASDAQ:ECOR) CFO Sells $28,080.00 in Stock

electroCore, Inc. (NASDAQ:ECOR) CFO Joshua Lev sold 3,000 shares of the company’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $9.36, for a total transaction of $28,080.00. Following the completion of the transaction, the chief financial officer owned 84,889 shares in the company, valued at approximately $794,561.04. The trade was a 3.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

electroCore Price Performance

ECOR stock traded down $0.18 during trading on Tuesday, hitting $9.47. 109,294 shares of the stock traded hands, compared to its average volume of 88,973. The stock has a market cap of $85.42 million, a price-to-earnings ratio of -5.70 and a beta of 0.93. electroCore, Inc. has a 1 year low of $4.41 and a 1 year high of $10.95. The firm’s 50 day moving average is $7.74 and its two-hundred day moving average is $7.21.

electroCore (NASDAQ:ECOR) last issued its earnings results on Thursday, August 6th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.09. electroCore had a negative net margin of 39.96% and a negative return on equity of 1,956.38%. The business had revenue of $9.45 million during the quarter, compared to analysts’ expectations of $9.49 million. As a group, analysts anticipate that electroCore, Inc. will post -1.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a research note on Wednesday, June 24th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $18.00.

Institutional Trading of electroCore

A number of large investors have recently made changes to their positions in ECOR. Two Sigma Investments LP lifted its position in electroCore by 20.8% during the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after purchasing an additional 4,231 shares during the period. Cubist Systematic Strategies LLC bought a new stake in electroCore in the 1st quarter worth approximately $153,000. WealthShield Partners LLC purchased a new stake in electroCore during the 1st quarter valued at $157,000. Jane Street Group LLC raised its stake in electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after buying an additional 19,599 shares during the last quarter. Finally, DRW Securities LLC bought a new position in shares of electroCore during the 4th quarter valued at $264,000. 26.74% of the stock is currently owned by institutional investors.

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.